Susquehanna International Group
CNST

Susquehanna International Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Susquehanna International Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-170,400
Closed -$5.76M – 14119
2021
Q2 		$5.76M Buy
170,400
+131,800
+341% +$3.36M ﹤0.01% 3777
2021
Q1 		$903K Buy
38,600
+11,900
+45% +$360K ﹤0.01% 8005
2020
Q4 		$769K Sell
26,700
-78,700
-75% -$1.98M ﹤0.01% 7300
2020
Q3 		$2.13M Buy
105,400
+1,000
+1% +$24.4K ﹤0.01% 4490
2020
Q2 		$3.14M Buy
+104,400
New +$3.76M ﹤0.01% 3729
2020
Q1 		– Sell
-19,300
Closed -$909K – 11185
2019
Q4 		$909K Buy
+19,300
New +$557K ﹤0.01% 5720

Susquehanna International Group's CNST Position: Q3 2021 in Review

Susquehanna International Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 19,013 shares — an estimated $643K sold.

Susquehanna International Group first reported a position in CNST in Q1 2020 and held it in 6 quarters. The position peaked at $1.26M in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Susquehanna International Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Susquehanna International Group sold 19,013 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $643K.
  • Susquehanna International Group first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
  • Susquehanna International Group's Constellation Pharmaceuticals, Inc. position peaked at $1.26M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.